Alcohol‐Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study-Reference-Cited by-同舟云学术

Alcohol‐Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study

Published:2019-01-15 Issue:5 Volume:69 Page:2271-2283
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Szabo Gyongyi¹,Kamath Patrick S.²,Shah Vijay H.²^ORCID,Thursz Mark³,Mathurin Philippe⁴,Addolorato Giovanni,Bataller Ramon,Burra Patrizia,Castera Laurent,Cortez Pinto Helena,Diehl Anna Mae,Gao Bin,Gilmore Sir Ian,Hampe Jochen,Jürgen Rehm,Karin Michael,Krag Alexander,Leon David,Leptak Christopher,Louvet Alexandre,Lucey Michael,McClain Craig,Nagy Laura,Pageaux Georges‐Philippe,Sanyal Arun,Schnabl Bernd,Tiniakos Dina,Trautwein Christian,Tsukamoto Hidekazu,

Affiliation:

1. Department of MedicineUniversity of Massachusetts Medical School Worcester MA US

2. Division of Gastroenterology and HepatologyMayo Clinic College of Medicine Rochester MN, US

3. Digestive Diseases Division, Department of Surgery & CancerImperial College London UK

4. Service des Maladies de l'Appareil Digestif Hôpital Claude Huriez Lille France

Funder

National Cancer Institute

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30369

Reference72 articles.

1. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

2. Global burden of alcoholic liver diseases

3. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data

4. Alcohol and liver disease in Europe – Simple measures have the potential to prevent tens of thousands of premature deaths

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MUP1 mediates urolithin A alleviation of chronic alcohol-related liver disease via gut-microbiota-liver axis;Gut Microbes;2024-06-18

2. Socio‐economic association of alcohol use disorder and cardiovascular and alcohol‐associated liver disease from 2010 to 2019;Alimentary Pharmacology & Therapeutics;2024-05-29

3. Alcohol-associated liver disease and behavioral and medical cofactors: unmet needs and opportunities;Frontiers in Public Health;2024-04-04

4. Extracellular vesicles as tools and targets in therapy for diseases;Signal Transduction and Targeted Therapy;2024-02-05

5. Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction–Associated Steatotic Liver Disease: Progress But With Challenges;Gastroenterology;2024-02